The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA). (Q35146115)

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The effects of corticotrophin releasing factor (CRF) and handling stress on behavior in the elevated plus-maze test of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Olfactory cues from an oxytocin-injected male rat can reduce energy loss in its cagemates

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effects of methylenedioxymethamphetamine on noradrenaline-evoked contractions of rat right ventricle and small mesenteric artery

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Increasing the selectivity of drug discrimination procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Fenfluramine-induced suppression of food intake and locomotor activity is differentially altered by the selective type A monoamine oxidase inhibitor clorgyline.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Chemical analysis of ecstasy pills

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine produce serotonergic neurotoxicity: possible role in methylenedioxyamphetamine-mediated neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effects of (+)-fenfluramine on 3,4-methylenedioxymethamphetamine (MDMA) discrimination in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Assessment of the MDA and MDMA Optical Isomers in a Stimulant-Hallucinogen Discrimination

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Time Course Analysis of the Discriminative Stimulus Effects of the Optical Isomers of 3,4-Methylenedioxymethamphetamine (MDMA)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Conditioned place preference: what does it add to our preclinical understanding of drug reward?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Chronic alcohol abuse and the acute sedative and neurophysiologic effects of midazolam

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

MDMA produces a conditioned place preference and elicits ejaculation in male rats: a modulatory role for the endogenous opioids

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Methylenedioxymethamphetamine's capacity to establish place preferences and modify intake of an alcoholic beverage.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

CGS 10746B, a novel dopamine release inhibitor, blocks the establishment of cocaine and MDMA conditioned place preferences

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Bufuralol 1'-hydroxylase activity of the rat. Strain differences and the effects of inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

3,4-methylenedioxymethamphetamine (ecstasy)-induced learning and memory impairments depend on the age of exposure during early development.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effects of designer drugs on the chicken embryo and 1-day-old chicken

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effects of ecstasy on aldosterone secretion in the rat in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

5HT3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Is hyperthermia the triggering factor for hepatotoxicity induced by 3,4-methylenedioxymethamphetamine (ecstasy)? An in vitro study using freshly isolated mouse hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Body temperature effect on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Assessment of the antidepressant-like effects of L-type voltage-dependent channel modulators.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The hyperthermic and neurotoxic effects of ‘Ecstasy’ (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The content of ecstasy tablets: implications for the study of their long-term effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Altered states: the clinical effects of Ecstasy.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Buspirone attenuates volitional alcohol intake in the chronically drinking monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Methylenedioxymethamphetamine (MDMA; 'Ecstasy') suppresses antigen specific IgG2a and IFN-gamma production

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Methylenedioxymethamphetamine-induced suppression of interleukin-1beta and tumour necrosis factor-alpha is not mediated by serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses IL-1beta and TNF-alpha secretion following an in vivo lipopolysaccharide challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Acute 3,4-methylenedioxymethamphetamine(MDMA) administration produces a rapid and sustained suppression of immune function in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The antinociceptive effects of 3,4-methylenedioxymethamphetamine (MDMA) in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") but not by fenfluramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The stimulatory and inhibitory components of cocaine's actions on the 5-HTP-induced 5-HT2A receptor response

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Dopaminergic regulation of cortical acetylcholine release

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Non-linear pharmacokinetics of MDMA ('ecstasy') in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Pharmacology of MDMA in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

An appraisal of the pharmacological and toxicological effects of a single oral administration of 3,4-methylenedioxymethamphetamine (MDMA) in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Citalopram reduces social interaction in rats by activation of serotonin (5-HT)(2C) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effects of idazoxan on 5-hydroxytryptamine-mediated behaviour in the mouse and rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The psychological and physiological effects of MDMA on normal volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamphetamine and (+/-)-3,4-methylenedioxyamphetamine in pigeons.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Three-choice discrimination among (+)-amphetamine, fenfluramine and saline in pigeons.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Animal models for predicting clinical efficacy of anxiolytic drugs: social behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effects of beta-carbolines in animal models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Cerebral oedema after MDMA ("ecstasy") and unrestricted water intake. Drug workers emphasise that water is not an antidote to drug

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The N-methyl-D-aspartate (NMDA) receptor antagonist, dextrorphan, prevents the neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Sympathomimetic actions of methylenedioxymethamphetamine in rat and rabbit isolated cardiovascular tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Stereochemistry of the metabolism of MDMA to MDA.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The effect of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Acute effects of methylenedioxymethamphetamine (MDMA) on several complex brain functions in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effects of MDMA on complex brain function in laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Recreational drug misuse: issues for the cardiologist

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effects of serotonin uptake blockade on food, water, and ethanol consumption in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Subarachnoid haemorrhage associated with MDMA abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Further investigation of the discriminative stimulus properties of MDA.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effect of 1-(3,4-methylenedioxyphenyl)-2-aminopropane and its optical isomers in PMMA-trained rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Investigation of MDMA-related agents in rats trained to discriminate MDMA from saline

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Stimulus effects of N-monoethyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDE) and N-hydroxy-1-(3,4-methylenedioxyphenyl)-2-aminopropane (N-OH MDA) in rats trained to discriminate MDMA from saline

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

MDMA stimulus generalization to the 5-HT(1A) serotonin agonist 8-hydroxy-2- (di-n-propylamino)tetralin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Initial characterization of PMMA as a discriminative stimulus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Methysergide potentiates the hyperactivity produced by MDMA in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

MDMA produces stimulant-like conditioned locomotor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Molecular genetics of the debrisoquin-sparteine polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Metabolic and thermoregulatory responses of the rat maintained in acrylic or wire-screen cages: implications for pharmacological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Neuroendocrine and cardiovascular effects of MDE in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Hyponatraemia, water intoxication and ‘ecstasy’

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

5-Hydroxytryptamine pathways in anxiety and its treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

5HT drugs in animal models of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Relationship of the structure of mescaline and seven analogs to toxicity and behavior in five species of laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

'Ecstasy' and intracerebral haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Life-threatening interactions between HIV-1 protease inhibitors and the illicit drugs MDMA and gamma-hydroxybutyrate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Serotonin transporters in ecstasy users

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Fatal interaction between ritonavir and MDMA

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Selective modulation of immune function resulting from in vitro exposure to methylenedioxymethamphetamine (Ecstasy).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effects of cocaine and amphetamine on acetylcholine release in the hippocampus and caudate nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphé nucleus slices

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Combined administration of a non-neurotoxic 3,4-methylenedioxymethamphetamine analogue with amphetamine produces serotonin neurotoxicity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

MDMA elicits behavioral and neurochemical sensitization in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

MDMA induced dopamine release in vivo: role of endogenous serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Corticosteroids in relation to fear, anxiety and psychopathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

In vitro release of [3H]5-hydroxytryptamine from fetal and maternal brain by drugs of abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Experimental hyperphenylalaninemia in the pregnant guinea pig: possible phenylalanine teratogenesis and p-chlorophenylalanine embryotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Molecular footprints of neurotoxic amphetamine action

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Toxic effect of MDMA on brain serotonin neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Behavioral suppression following 3,4-methylenenedioxymethamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Metabolism of methylenedioxyphenyl compounds by rabbit liver preparations. Participation of different cytochrome P450 isozymes in the demethylenation reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

A frequency analysis of behavior components of the serotonin syndrome produced by p-chloroamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Investigation of the prejunctional alpha2-adrenoceptor mediated actions of MDMA in rat atrium and vas deferens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

MDMA and memory: the acute and chronic effects of MDMA in pigeons performing under a delayed-matching-to-sample procedure.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

MDMA and d-amphetamine produce comparable effects in pigeons performing under a multiple fixed-ratio interresponse-time-greater-than-t schedule of food delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Cardiovascular effects of 3,4-methylenedioxymethamphetamine. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Carrier-mediated release of neurotransmitters

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Long-term central 5-HT depletions resulting from repeated administration of MDMA enhances the effects of single administration of MDMA on schedule-controlled behavior of rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine in the rat: identification of metabolites using an ion trap detector

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the elevated plus-maze: a comparison with amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Serotonergic modulation of 3,4-methylenedioxymethamphetamine (MDMA)-elicited reduction of response rate but not rewarding threshold in accumbal self-stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Enzymatic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effects of 3,4-methylenedioxy-methamphetamine (MDMA) on anxiety in mice tested in the light-dark box.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

MDMA ("ecstasy") exhibits an anxiogenic-like activity in social encounters between male mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Acute Toxicity of 3,4-Methylenedioxymethamphetamine (MDMA) in Sprague–Dawley and Dark Agouti Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Dopaminergic stimulation disrupts sensorimotor gating in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Reinforcing effects of certain serotonin-releasing amphetamine derivatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Caveat emptor: editors beware

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effects of the 5-HT2C/2B antagonist SB 206553 on hyperactivity induced by cocaine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

LSD Produces Conditioned Place Preference in Male But Not Female Fawn Hooded Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

3-4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Rewarding effects of the optical isomers of 3,4-methylenedioxy-methylamphetamine ('Ecstasy') and 3,4-methylenedioxy-ethylamphetamine ('Eve') measured by conditioned place preference in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Psychomotor stimulant effects of d-amphetamine, MDMA and PCP: aggressive and schedule-controlled behavior in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Methylenedioxymethamphetamine induces spontaneous tail-flicks in the rat via 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

2,5-Bis-(glutathion-S-yl)-alpha-methyldopamine, a putative metabolite of (+/-)-3,4-methylenedioxyamphetamine, decreases brain serotonin concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Pathology of deaths associated with "ecstasy" and "eve" misuse

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effects of para-chlorophenylalanine on pregnancy in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Repeated administration of 3,4-methylenedioxymethamphetamine augments cocaine's action on dopamine in the nucleus accumbens:

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Ecstasy (MDMA): a review of its possible persistent psychological effects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

(+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Behavioral effects of (+-) 3,4-methylenedioxyamphetamine (MDA) and (+-) 3,4-methylenedioxymethamphetamine (MDMA) in the pigeon: interactions with noradrenergic and serotonergic systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effect of once weekly treatment with 3,4-methylenedioxymethamphetamine on schedule-controlled behavior in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Behavioral profile of 3,4-methylenedioxy-methamphetamine (MDMA) in agonistic encounters between male mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Acute and subchronic effects of MDMA ("ecstasy") on anxiety in male mice tested in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Acute effects of 3,4-methylenedioxymethamphetamine on brain serotonin synthesis in the dog studied by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Rapid analysis of illicit drugs by mass spectrometry: results from seizures in Ireland

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Drug discrimination studies with MDMA and amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effects of acute and chronic fenfluramine on self-stimulation and its facilitation by amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Immunomodulating properties of MDMA alone and in combination with alcohol: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

MDMA: further evidence that its action in the medial prefrontal cortex is mediated by the serotonergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The action of (+/-)-MDMA on medial prefrontal cortical neurons is mediated through the serotonergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Anxiolytic effect of the 5-HT1A compounds 8-hydroxy-2-(di-n-propylamino) tetralin and ipsapirone in the social interaction paradigm: evidence of a presynaptic action

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effects of MDMA ('ecstasy') on firing rates of serotonergic, dopaminergic, and noradrenergic neurons in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

d-Amphetamine and phencyclidine alone and in combination: Effects on fixed-ratio and interresponse-time-greater-than-t responding of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

A new method to monitor drugs at dance venues

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Reinforcing effects of MDMA ("ecstasy") in drug-naive and cocaine-trained rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Toxic effect of MDMA on brain serotonin neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhance pressing for rewarding brain stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Attenuation of alcohol consumption by MDMA (ecstasy) in two strains of alcohol-preferring rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy').

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Patterns of recreational drug use at dance events in Edinburgh, Scotland

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

MDMA enhances associative and nonassociative learning in the rabbit.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The effect of MDA and MDMA ("Ecstasy") isomers in combination with pirenpirone on operant responding in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Amphetamine analogs have differential effects on DRL 36-s schedule performance.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Discriminative profile of MDMA.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effect of serotonin depletion by p-chlorophenylalanine upon discriminative behaviours

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Drug-drug discrimination: stimulus properties of drugs of abuse upon a serotonergic-dopaminergic continuum.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

'Candyflipping': synergistic discriminative effect of LSD and MDMA.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Neurotoxicity of MDMA: neurochemical effects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Ecstasy counteracts catalepsy in rats, an anti-parkinsonian effect?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effect of 3,4-methylenedioxymethamphetamine (MDMA) on hippocampal dopamine and serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Analysis of illicit ecstasy tablets: implications for clinical management in the accident and emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Oxidative stress as a precursor to the irreversible hepatocellular injury caused by hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Behavioral and neurochemical effects of prenatal methylenedioxymethamphetamine (MDMA) exposure in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Acute inactivation of tryptophan hydroxylase by amphetamine analogs involves the oxidation of sulfhydryl sites

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Increasing MDMA use among college students: results of a national survey

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Receptor pharmacology of MDMA and related hallucinogens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Differential effects of phencyclidine and MDA on complex operant behavior in monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Effects of phencyclidine, ketamine and MDMA on complex operant behavior in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The use of drugs within the techno party scene in European metropolitan cities

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Vascular actions of 3,4-methylenedioxymethamphetamine in alpha(2A/D)-adrenoceptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Caveat emptor: editors beware

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

1 reference

7 January 2021

Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Serotonergic modulation of the rat pup ultrasonic isolation call: studies with 5HT1 and 5HT2 subtype-selective agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Contents of "ecstasy"

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

The neurobiology of social recognition, approach, and avoidance

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

Tolerance and cross-tolerance to 3,4-methylenedioxymethamphetamine (MDMA), methamphetamine and methylenedioxyamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021

A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (+/-)-MDMA in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2803%2900031-9

7 January 2021